Clinician’s Update on Omega-3s in ASCVD Risk Reduction

Emerging Data on New Therapy Combinations for HFrEF: Raising Clinician Awareness

Expert Insights: Managing Patients with CKD, Hyperkalemia, and Continued RAASi Therapy Through a Case Study Approach

New Therapies Offer Improved Outcomes in HFrEF Management

New Opportunities to Manage Aortic Stenosis with TAVR

Clinical Implications of Managing Iron Deficiency from AFFIRM-AHF

AHA 2020: Neue Erkenntnisse zu Eisenmangel und Herzinsuffizienz

AHA 2020: New Insights on Iron Deficiency and Heart Failure

The New Role of Omega-3 Fatty Acids in Reducing ASCVD Risk in Women: Expert Dialogue

Common Misconceptions About Iron Deficiency in Heart Failure and What to Do About It

Management of Heart Failure: Time to Consider New Options?

Omega-3 Fatty Acids in Patients with ASCVD Risk: The Role of Icosapent Ethyl (IPE)

Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients with CV Risks?